Abstract 14623: ICAM-1 Mediates Hyperhomocysteinemia Accelerated Arteriolar Thrombosis and Endothelial -Platelets Interaction
Shu Meng,Soochong Kim,Xiaohua Jiang,Zhongjian Cheng,Satya P. Kunapuli,Rolando E. Rumbaut,Xiaofeng Yang,Hong Wang
IF: 37.8
2012-01-01
Circulation
Abstract:Background: Hyperhomocysteinemia (HHcy) is an established risk factor for atherothrombogenic diseases. In this study we investigated the effect of HHcy on EC-platelets interaction and its role in thrombosis. Methods and Results: We used a novel mouse model of HHcy (plasma homocysteine, Hcy 80 μ M) in which a Zn 2+ inducible human cystathionine β -synthase ( C BS ) transgene was introduced to circumvent the neonatal lethality of Cbs deficiency ( Tg-hCBS Cbs −/− mice). Hcy-lowering therapy was performed by giving ZnSO 4 water to induce human CBS transgene expression in adult mice. Thrombus formation was examined by photo-dye induced cremaster microvasculature thrombosis using intra-vital microscope, which preserved the endothelium, and by FeCl 3 -induced carotid artery thrombosis, which denudated the endothelium. HHcy accelerated cremaster arteriolar thrombosis and decreased blood flow cessation time from 41.8 min in control mice to 30.5 min in Tg-hCBS Cbs −/− mice. Venular blood flow cessation time was slightly decreased from 5.6 to 5.0 min. Hcy-lowering therapy reduced Hcy level from 80 μ M to 2 μ M after 2 weeks of ZnSO 4 water and prolonged arteriolar blood cessation time from 30.5 to 37.8 min. Interestingly, FeCl 3 -induced carotid artery thrombosis did not change. Hcy did not potentiate aggregation and secretion of washed human platelets from healthy donor treated with Hcy (50, 100 μ M) and from Tg-hCBS Cbs −/− mice. However, ICAM-1 levels, but not VCAM-1, were increased in cremaster tissues from Tg-hCBS Cbs −/− mice by western blot. In cultured human umbilical vein ECs (HUVEC), Hcy (100 μ M, 24h) promoted human platelet adhesion by 200% in static adhesion assay. Using western blot, FACS and RT-PCR, we found that Hcy increased protein and mRNA levels of ICAM-1, but not that of VCAM-1, in HUVEC. ICAM-1 blocking antibody partially reversed Hcy-increased platelets adhesion to HUVEC. Finally, Hcy induced ICAM-1 expression and reduced DNA methylation on ICAM-1 promoter, which were mimicked by DNA methyltransferase inhibitor azacytidine, and histone deacetylase inhibitors sodium butyrate and trichostatin A. Conclusion: HHcy accelerates arteriolar thrombosis and increases EC-platelets interaction via ICAM-1 induction partially through promoter hypomethylation.